Results 91 to 100 of about 896 (121)

Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations

, 2009
Use of postmenopausal hormone replacement therapy (HRT) has been associated with an elevated risk of gynecological cancers. There is evidence that the effect differs with the type of hormone used.
Jick, S. S., Schneider, C., Meier, C. R., Meier CR, Schneider C, Jick SS, C. Schneider, S. S. Jick, C. R. Meier   +8 more
core   +1 more source

Immunotherapy for recurrent miscarriage due to alloimmune reasons [PDF]

Гинекология, 2017
The article presents the current understanding of the pathogenetic mechanisms of habitual abortion realization of alloimmune genesis and proposed methods of immunotherapy. The mechanisms of the impact and effectiveness of various drugs and cell therapies.
V A Saribegova, N K Tetruashvili, L V Krechetova, A A Agadzhanova   +3 more
doaj  

Adjunctive effects of acupuncture and moxibustion in women with premature ovarian insufficiency receiving hormone replacement therapy: protocol for a multicenter, assessor-blinded, 2 × 2 factorial randomized controlled trial

Frontiers in Endocrinology
IntroductionPremature ovarian insufficiency (POI) is characterized by impaired ovarian function before 40 years of age and is associated with menstrual disturbance, infertility, hypoestrogenic symptoms, psychological distress, and long-term health risks.
Chunxia Lu, Chunxia Lu, Tingting Ye, Jin Cui, Jin Cui, Bo Chen   +5 more
doaj   +1 more source

Resolution of the I Ukrainian forum on miscarriages

Репродуктивная эндокринология
Today, there is an urgent need to develop and implement a regulatory document on abortion. This is due to the catastrophic state of reproduction of the Ukrainian population – the annual decrease in the number of labor, birth rates and the demographic ...
T.F. Tatarchuk, N.P. Honcharuk, N.Y. Pedachenko, D.H. Konkov, A.M. Kalinchuk, E.H. Manzhalii, T.K. Znamenska, T.M. Tutchenko, M.V. Haytovych   +8 more
doaj   +1 more source

Gu Ben An Tai decoction combined with dydrogesterone for early threatened abortion secondary to spleen and kidney deficiency: a retrospective observational study

Contraception and Reproductive Medicine
Background In this retrospective observational study, we aimed to evaluate the clinical efficacy and safety of Gu Ben An Tai Decoction (GBATD) combined with dydrogesterone for treating threatened abortion (TA).
Xuebing Li, Yang Wang, Zhuoxuan Su, Lu Pei, Yongwei Li, Chunxia Wang   +5 more
doaj   +1 more source

Fewer good-quality cleavage embryos in dydrogesterone-primed ovarian stimulation compared to GnRH antagonist protocol in POSEIDON group 4 patients

Journal of the Formosan Medical Association
Objective: To compare the in vitro fertilization (IVF) outcomes of the progestin-primed ovarian stimulation (PPOS) protocol using dydrogesterone and the GnRH antagonist (GnRH-ant) protocol in POSEIDON group 4 patients.
Nguyen Thi Lien Huong, Bui Thi Hanh, Nguyen Thi Bich Van, Phi Thi Tu Anh, Hoang Bao Long, Le Duc Thang, Tran Thu Thuy, Nguyen Thi Minh Thu, Dang Tuan Anh, Phan Ngoc Quy, Le Quang Do, Than Trong Thach, Jean Noel Hugues, Do Van Tien, Le Hoang   +14 more
doaj   +1 more source

Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women.

, 1999
peer reviewedOBJECTIVE: To determine in postmenopausal women the long-term effects on carbohydrate metabolism of the administration of oral micronized 17 beta-estradiol (2 mg/day continuously) and cyclical dydrogesterone (10 mg/day for 14 days per 28-day
Gaspard, Ulysse, Scheen, André, Jaminet, C., Lefebvre, Pierre, Wery, Olivier   +4 more
core   +1 more source

Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules

, 2011
Clinical observations and basic studies show that progesterone and progestins have a variable influence on endothelial function. Dydrogesterone (DG) is a widely used progestin, but its endothelial actions have not been thoroughly assessed. In this study,
MANNELLA, PAOLO, Palla G, Garibaldi S, SIMONCINI, TOMMASO, Fu XD, Spina S, Genazzani AD, GENAZZANI, ANDREA, Gopal S, Polak K, A. R. Genazzani, X.-D. Fu, S. Garibaldi, P. Mannella, A. D. Genazzani, G. Palla, K. Polak, T. Simoncini, S. Gopal, S. Spina   +19 more
core   +1 more source

A comparative study of norethisterone and dydrogesterone in the treatment of heavy menstrual bleeding [PDF]

Background: HMB is described as bleeding for >7 days or >80 ml per cycle/ having a higher than 100 score on the pictorial blood assessment chart (PBAC). Medical management is the first line of treatment.
M., Narayanaswamy, Nilofer
core   +1 more source

Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats

, 2008
To investigate the effects of dydrogesterone (DYD), a synthetic progestin largely used in hormone therapy, on the central nervous system by studying two markers of the neuroendocrine function: the neurosteroid allopregnanolone and the opioid beta ...
CASAROSA E, BEGLIUOMINI S, NINNI F, LENZI E, PLUCHINO N, GENAZZANI, ANDREA, LUISI S, CELA V, FRESCHI L   +8 more
core